Water dispersible magnetite nanoparticles influence the efficacy of antibiotics against planktonic and biofilm embedded enterococcus faecalis cells

Anaerobe

Volumn 22, Issue , 2013, Pages 14-19

  Chifiriuc, Mariana Carmen ^a   Grumezescu, Alexandru Mihai ^b   Andronescu, Ecaterina ^b   Ficai, Anton ^b   Cotar, Ani Ioana ^a   Grumezescu, Valentina ^b,c   Bezirtzoglou, Eugenia ^d   Lazar, Veronica ^a   Radulescu, Radu ^e  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^c NATIONAL INSTITUTE FOR LASER   (Romania)

^d DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^e Universitary Emergency Hospital Bucharest   (Romania)

Author keywords

Antibiotics; Biofilms; Disk diffusion; Enterococcus faecalis; Magnetite nanoparticles; Minimal inhibitory concentration

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; MAGNETITE NANOPARTICLE; PENICILLIN DERIVATIVE; STREPTOMYCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BIOFILM; CONTROLLED STUDY; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PRIORITY JOURNAL;

ANTIBIOTICS; BIOFILMS; DISK DIFFUSION; ENTEROCOCCUS FAECALIS; MAGNETITE NANOPARTICLES; MINIMAL INHIBITORY CONCENTRATION;

ANTI-BACTERIAL AGENTS; BIOFILMS; DELAYED-ACTION PREPARATIONS; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MAGNETITE NANOPARTICLES; MICROBIAL VIABILITY; PLANKTON; WATER;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS;

EID: 84880747615     PISSN: 10759964     EISSN: 10958274     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2013.04.013     Document Type: Article

References (50)

1. Richards M.J., Edwards J.R., Culver D.H., Gaynes R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000, 21:510-515.
2. Jones M.E., Draghi D.C., Thornsberry C., Karlowsky J.A., Sahm D.F., Wenzel R.P. Emerging resistance among bacterial pathogens in the intensive care unit - a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 2004, 3:14.
3. Sandoe J.A.T., Witherden I.R., Cove J.H., Heritage J., Wilcox M.H. Correlation between enterococcal biofilm formation invitro and medical-device-related infection potential invivo. JMed Microbiol 2003, 52:547-550.
4. Fluit A.C., Schmitz F.J., Verhoef J. Frequency of isolation of pathogens from bloodstream, nosocomial pneumonia, skin and soft tissue, and urinary tract infections occurring in European patients. Eur J Clin Microbiol Infect Dis 2001, 20:188-191.
5. Pei X., Lu X., Liu J., Liu D., Yang Y., Ostrikov K., et al. Inactivation of a 25.5μm Enterococcus faecalis biofilm by a room-temperature, battery-operated, handheld air plasma jet. JPhys D Appl Phys 2012, 45:165205.
6. Mohamed J.A., Huang D.B. Biofilm formation by enterococci. JMed Microbiol 2007, 56:1581-1588.
7. Fisher K., Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology-SGM 2009, 155:1749-1757.
8. Taylor E., Webster T.J. Reducing infections through nanotechnology and nanoparticles. Int J Nanomed 2011, 6:1463-1473.
9. Zhang L., Jiang Y., Ding Y., Povey M., York D. Investigation into the antibacterial behaviour of suspensions of ZnO nanoparticles (ZnO nanofluids). JNanoparticle Res 2007, 9:479-489.
10. Rbab A.S., Wilson L.B., Ashari P., Jordan E.K., Lewis B.K., Frank J.A. Amodel of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 2005, 18:383-389.
11. Azam A., Ahmed A.S., Oves M., Khan M.S., Habib S.S., Memic A. Antimicrobial activity of metal oxide nanoparticles against Gram-positive and Gram-negative bacteria: a comparative study. Int J Nanomed 2012, 7:6003-6009.
12. Karmali R.S., Bartakke A., Borker V.P., Rane K.S. Bactericidal action of N doped ZnO in sunlight. Biointerface Res Appl Chem 2011, 1:57-63.
13. Anghel I., Grumezescu A.M., Andronescu E., Anghel A.G., Ficai A., Saviuc C., et al. Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development. Nanoscale Res Lett 2012, 7:501.
14. Limban C., Grumezescu A., Saviuc C., Voicu G., Chifiriuc C. Optimized anti-pathogenic agents based on core/shell nanostructures and 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. Int J Mol Sci 2012, 13:12584-12597.
15. 12 nanostructures and 2-((4-ethylphenoxy) methyl)-N-(substituted-phenylcarbamothioyl)-benzamides. Nanoscale Res Lett 2012, 7:513.
16. Puckett S.D., Taylor E., Raimondo T., Webster T.J. The relationship between the nanostructure of titanium surfaces and bacterial attachment. Biomaterials 2010, 31:706-713.
17. 2. JBiomed Mater Res Part A 2006, 78A:595-604.
18. Sousa C., Botelho C., Oliveira R. Science against microbial pathogens: communicating current research and technological advances. Nanotechnology applied to medical biofilms control 2011, 878-888. Formatex. A. Méndez-Vilas (Ed.).
19. Crisante F., Francolini I., Bellusci M., Martinelli A., D'Ilario L., Piozzi A. Antibiotic delivery polyurethanes containing alb umin and polyallylamine nanoparticles. Eur J Pharm Sci 2009, 36:555-564.
20. Varshosaz J. Insulin delivery systems for controlling diabetes. Recent Pat Endocr Metab Immune Drug Discov 2007, 1:25-40.
21. Grumezescu A.M., Holban A.M., Andronescu E., Tomoiaga M., Ficai A., Bleotu c., et al. Microbiological applications of a new water dispersible magnetic nanobiocomposite. Lett Appl NanoBioSci 2012, 1:83-90.
22. Grumezescu A.M., Holban A.M., Andronescu E., Ficai A., Bleotu C., Chifiriuc M.C. Water dispersible metal oxide nanobiocomposite as potentiator of the antimicrobial activity of kanamycin. Lett Appl NanoBioSci 2012, 1:77-82.
23. Grumezescu A.M., Andronescu E., Ficai A., Ficai D., Huang K.S., Gheorghe I., et al. Water soluble magnetic biocomposite with pontetial applications for the antimicrobial therapy. Biointerface Res Appl Chem 2012, 2:469-475.
24. http://serc.carleton.edu/research_education/geochemsheets/techniques/XRD.html.
25. http://www.empa.ch/plugin/template/empa/%2a/114255.
26. 12 core/shell nanosystem. Lett Appl NanoBioSci 2012, 1:31-35.
27. Gu H., Xu K., Xu C., Xu B. Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem Commun (Camb) 2006, 7:941-949.
28. 4-Au, nanoparticles for biomolecule immobilization and detection. JNanopart Res 2010, 12:1187-1196.
29. Chang J.H., Kang K.H., Choi J., Jeong Y.K. High efficiency protein separation with organosilane assembled silica coated magnetic nanoparticles. Superlat Microstruct 2008, 44:442-448.
30. Huang Y.F., Wang Y.F., Yan X.P. Amine functionalized magnetic nanoparticles for rapid capture and removal of bacterial pathogens. Environ Sci Technol 2010, 447908-447913.
31. Dong H., Huang J., Koepsel R.R., Ye P., Russell A.J., Matyjaszewski K. Recyclable antibacterial magnetic nanoparticles grafted with quaternized poly(2-(dimethylamino)ethyl methacrylate) brushes. Biomacromolecules 2011, 12:1305-1311.
32. 4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies. Pharm Res 2012, 29:1328-1343.
33. Lee E.S., Lim C., Song H.T., Yun J.M., Lee K.S., Lee B.J., et al. Ananosized delivery system of superparamagnetic iron oxide for tumor MR imaging. Int J Pharm 2012, 439:342-348.
34. Meng X., Seton H.C., Lule T., Prior I.A., Thanh N.T., Song B. Magnetic CoPt nanoparticles as MRI contrast agent for transplanted neural stem cells detection. Nanoscale 2011, 3:977-984.
35. Masoudi A., Hosseini H.R.M., Morteza S., Reyhani S., Shokrgozar M.A., Oghabian M.A., et al. Long-term investigation on the phase stability, magnetic behavior, toxicity, and MRI characteristics of superparamagnetic Fe/Fe-oxide core/shell nanoparticles. Int J Pharm 2012, 439:28-40.
36. Mihaiescu D.E., Grumezescu A.M., Balaure P.C., Mogosanu D.E., Traistaru V. Magnetic scaffold for drug targeting: evaluation of cephalosporins controlled release profile. Biointerface Res Appl Chem 2011, 1:191-195.
37. Chen X., Lv H., Ye M., Wang S., Ni E., Zeng F., et al. Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting. Int J Pharm 2012, 426:248-255.
38. Grumezescu A.M., Saviuc C., Holban A., Hristu R., Croitoru C., Stanciu G., et al. Magnetic chitosan for drug targeting and invitro drug delivery response. Biointerface Res Appl Chem 2011, 1:160-165.
39. Huang C., Tang Z., Zhou Y., Zhou X., Jin Y., Li D., et al. Magnetic micelles as a potential platform for dual targeted drug delivery in cancer therapy. Int J Pharm 2012, 429:113-122.
40. Andronescu E., Grumezescu A.M., Ficai A., Gheorghe I., Chifiriuc M., Mihaiescu D.E., et al. Invitro efficacy of antibiotic magnetic dextran microspheres complexes against Staphylococcus aureus and Pseudomonas aeruginosa strains. Biointerface Res Appl Chem 2012, 2:332-338.
41. Chomoucka J., Drbohlavova J., Huska D., Adam V., Kizek R., Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharm Res 2010, 62:144-149.
42. Chifiriuc C., Grumezescu V., Grumezescu A.M., Saviuc C., Lazǎr V., Andronescu E. Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett 2012, 7:209.
43. Saviuc C., Grumezescu A.M., Holban A., Chifiriuc C., Mihaiescu D., Lazar V. Hybrid nanostructurated material for biomedical applications. Biointerface Res Appl Chem 2011, 1:64-71.
44. Alphandéry E., Guyot F., Chebbi I. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia. Int J Pharm 2012, 434:444-452.
45. Laurent S., Dutz S., Häfeli U.O., Mahmoudi M. Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 2011, 166:8-23.
46. Arciola C.R., Baldassarri L., Campoccia D., Creti R., Pirini V., Huebner J., et al. Strong biofilm production, antibiotic multi-resistance and high gelE expression in epidemic clones of Enterococcus faecalis from orthopaedic implant infections. Biomaterials 2008, 29:580-586.
47. Erlandsen S.L., Kristich C.J., Dunny G.M. Ultrastructure of Enterococcus faecalis biofilms. Biofilms 2004, 1:131-137.
48. Durdureanu-Angheluta A., Pinteala M., Simionescu B.C. Tailored and functionalized magnetite particles for biomedical and industrial applications. Materials science and technology 2012, InTech. S. Hutagalung (Ed.).
49. Ma L.M., Conover M., Lu H.P., Parsek M.R., Bayles K., Wozniak D.J. Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathogens 2009, 5:e1000354.
50. Flemming H.C., Wingender J. The biofilm matrix. Nature Rev Microbiol 2010, 8:623-633.